Barclays
ADPT

Barclays’s Adeptus Health Inc ADPT Stock Holding History

Barclays’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,000
Closed -$4K – 7239
2017
Q1 		$4K Buy
2,000
+1,700
+567% +$9.54K ﹤0.01% 6369
2016
Q4 		$2K Buy
+300
New +$5.52K ﹤0.01% 6424

Other funds holding ADPT

PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Barclays's ADPT Position: Q2 2017 in Review

Barclays sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 10,349 shares — an estimated $18K sold.

Barclays first reported a position in ADPT in Q4 2014 and held it in 9 quarters. The position peaked at $1.06M in Q4 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Barclays reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Barclays sold 10,349 Adeptus Health Inc shares in Q2 2017, an estimated $18K.
  • Barclays first reported a position in Adeptus Health Inc in Q4 2014 and held it in 9 quarters.
  • Barclays's Adeptus Health Inc position peaked at $1.06M in Q4 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.